Rigel Pharmaceuticals | Creditori Commerciali

Prezzo Delle Azioni
33.52
Cambio Giornaliero
-1.11 -3.19%
Mensile
-4.11%
Annuale
51.79%
Q1 Previsione
33.68




Creditori Commerciali Cambiamento Data
Agenus USD 85.29M 10.89M 2025-09
Amgen USD 20.89B 1.25B 2025-12
Anika Therapeutics USD 4.73M 39K 2025-09
Arrowhead Research USD 32.94M 15.26M 2025-12
AstraZeneca USD 25.28B 252M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Celldex Therapeutics USD 1.18M 3.09M 2025-12
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Heron Therapeutics USD 12.02M 20K 2025-09
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
Ligand Pharmaceuticals USD 3.24M 24.52M 2025-12
MacroGenics USD 5.94M 1.28M 2025-09
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Pfizer USD 5.02B 142M 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Veracyte USD 4.59M 916K 2025-12


Rigel Pharmaceuticals Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.